Multiple resistant staphylococci that cause significant morbidity and mortality are the leading cause of nosocomial infections. Meanwhile, methicillin-resistant Staphylococcus aureus (MRSA) also spreads in the community, where highly virulent strains infect children and young adults who have no predisposing risk factors. Although some treatment options remain, the search for new antibacterial targets and lead compounds is urgently required to ensure that staphylococcal infections can be effectively treated in the future. Promising targets for new antibacterials are gene products that are involved in essential cell functions. In addition to antibacterials, active and passive immunization strategies are being developed that target surface components of staphylococci such as cell wall-linked adhesins, teichoic acids and capsule or immunodominant antigens.
Novel targets for antibiotics in Staphylococcus aureus. Publishing Authors By Initials
Novel targets for antibiotics in Staphylococcus aureus. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Future microbiology
VOLUME: 2
Page Numbers: 655-66
Journal Abbreviation:
ISSN: 1746-0921
DAY: 28
MONTH: Dec
YEAR: 2007
Novel targets for antibiotics in Staphylococcus aureus. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 101278120
Novel targets for antibiotics in Staphylococcus aureus. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Novel targets for antibiotics in Staphylococcus aureus. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Novel targets for antibiotics in Staphylococcus aureus.
AFFILIATION: University of Würzburg, Institute for Molecular Infection Biology, Röntgenring 11, 97070 Würzburg, Germany. knut.ohlsen@mail.uni-wuerzburg.de
Country: England
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Future Microbiol
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Novel targets for antibiotics in Staphylococcus aureus Related Publications